Showing results (41-50 of 51) with videos related to
Sort By:
Pageof 6
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
Autologous transplantation for diffuse aggressive non-Hodgkin's lymphoma in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant RegistryJ M Vose, M J Zhang, P A Rowlings, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1997
Randomized trial of CVPP for three versus six cycles in favorable-prognosis and CVPP versus AOPE plus radiotherapy in intermediate-prognosis untreated Hodgkin's diseaseS Pavlovsky, E Schvartzman, F Lastiri, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Meta-analysis of chemotherapy versus combined modality treatment trials in Hodgkin's disease. International Database on Hodgkin's Disease Overview Study GroupM Loeffler, O Brosteanu, D Hasenclever, et al.Cancer|October 1, 1978
Evaluation of intensification and maintenance programs in the treatment of acute lymphoblastic leukemiaF Sackmann-Muriel, E Svarch, M Eppinger-Helft, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1996
Multivariate analyses of prognostic factors associated with hematopoietic recovery in autograft patients with different sources of progenitor cells. A GATMO experience. Argintine Group of Bone Marrow TransplantS Pavlovsky, B Koziner, G Milone, et al.Leukemia|March 27, 2009
Is the International Staging System superior to the Durie-Salmon staging system? A comparison in multiple myeloma patients undergoing autologous transplantP N Hari, M-J Zhang, V Roy, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 21, 2006
Second malignancy risk associated with treatment of Hodgkin's lymphoma: meta-analysis of the randomised trialsJ Franklin, A Pluetschow, M Paus, et al.Leukemia|April 23, 2010
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and managementR A Kyle, B G M Durie, S V Rajkumar, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
Bone marrow transplants from HLA-identical siblings in advanced Hodgkin's diseaseJ L Gajewski, G L Phillips, K A Sobocinski, et al.Bone Marrow Transplantation|April 21, 2001
Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR)H M Lazarus, F R Loberiza, M J Zhang, et al.Pageof 6